Abstract
AbstractIn order to study the pharmacodynamic effects of drugs on dopamine and serotonin metabolism, a reversed-phase HPLC assay coupled with electrochemical detection (ECD) for measuring plasma concentrations of 3,4-dihydroxyphenylacetic acid (DOPAC) and 5-hy-droxyindoleacetic acid (5-HIAA) was developed. The system was operated isocratically using a mobile phase of aqueous 0.03MKH2PO4 buffer containing 0.15mM EDTA in methanol (8.75:1.25), with a final pH of 4.0. The flow rate was set at 1.5mL/min, and potentials at +450mV. Using a signal to noise ratio of >3, the minimum detection limit assessed by direct on-column injection of a standard solution for DOPAC and 5-HIAA was <1pg. The assays were linear from basal concentrations (1–10ng/mL) to 100ng/mL. The intra- and interassay variations were <10% and <20%, respectively.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
